...
首页> 外文期刊>ANZ journal of surgery >Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?
【24h】

Does meeting the Milan criteria at the time of recurrence of hepatocellular carcinoma after curative resection have an impact on prognosis?

机译:在治疗切除后,在肝细胞癌复发时是否会达到米兰标准对预后的影响?

获取原文
获取原文并翻译 | 示例

摘要

Background The survival outcomes of recurrent hepatocellular carcinoma (HCC) after curative resection remain unclear due to lack of clear basis for the selection of treatment option. We investigated overall survival (OS) after intrahepatic recurrence and re‐recurrence free survival (rRFS) of the patients with recurrent HCC, and whether Milan criteria (MC) status at resection and recurrence impacts on OS and rRFS. Method We enrolled 959 patients who experienced recurrence after primary hepatic resection for HCC. We divided the cohort into four groups according to MC at two periods: IN‐rIN MC (HCC within MC at the time of resection‐recurrence within MC), IN‐rOUT MC (HCC within MC at the time of resection‐recurrence outside MC), OUT‐rIN MC (HCC outside MC at the time of resection‐recurrence within MC), and OUT‐rOUT MC (HCC outside MC at the time of resection‐recurrence outside MC). Results In the entire cohort, 1‐, 3‐, and 5‐year OS after recurrence was 81.0%, 55.7%, and 45.8%, respectively, while rRFS was 63.7%, 46.1%, and 42.0%, respectively. The IN‐rIN MC group had the best outcomes (5‐year OS and rRFS, 54.5% and 45.7%, respectively). The IN‐rOUT and OUT‐rIN MC groups had better 5‐year OS outcomes than the OUT‐rOUT MC group (46.5%, 38.6%, and 24.8%, respectively; P ??0.05). However, 5‐year rRFS did not differ among the three groups (37.5%, 36.6%, and 31.9%, respectively; P ??0.05). Conclusion Survival after first recurrence following curative primary resection for HCC was affected by MC at both time of resection and recurrence. Both the IN‐rOUT and OUT‐rIN MC groups with similar survival outcomes can be saved via curative treatment.
机译:背景技术疗法切除术后复发性肝细胞癌(HCC)的存活结果由于缺乏明确的选择选择方法而持续不明确。我们在肝内复发后的肝内复发和再复发的患者的肝脏恢复生存(RRF)以及米兰标准(MC)在切除和复发对OS和RRF的影响中进行重新复发的存活率(RRF)。方法我们注册了959名患者经历过肝切除术治疗后的患者的患者。根据两个时期MC将群组分为四组:在-RIN MC(在MC中重新发生的时间内MC中MC),在MC中的RIN-RIT MC(MC中MC内的HCC) ),外rin mc(在MC中的重复发生时的HCC外部MC),并且在MC外切除术时MC的OUT-RAT-rut MC(HCC外部MC)。结果在复发后的整个队列,1-,3-和5年的OS中分别为81.0%,55.7%和45.8%,而RRF分别为63.7%,46.1%和42.0%。 RIN MC集团分别具有最佳成果(分别为5年的OS和RRF,54.5%和45.7%)。溃败和外rin MC组具有比超出溃败MC组的更好的5年OS结果(46.5%,38.6%和24.8%; p?0.05)。然而,5年的RRF在三组中没有差异(分别为37.5%,36.6%和31.9%; P?0.05)。结论疗法后复发后的生存在疗法初级切除后,MC在切除和复发两次受MC的影响。可以通过疗法治疗挽救具有相似生存结果的溃败和外rin MC组。

著录项

  • 来源
    《ANZ journal of surgery 》 |2019年第3期| 共7页
  • 作者单位

    Department of SurgerySeoul National University College of MedicineSeoul Republic of Korea;

    Department of SurgerySeoul National University College of MedicineSeoul Republic of Korea;

    Department of SurgerySamsung Medical Center Sungkyunkwan University School of MedicineSeoul;

    Department of SurgerySeoul National University College of MedicineSeoul Republic of Korea;

    Department of SurgerySamsung Medical Center Sungkyunkwan University School of MedicineSeoul;

    Department of SurgerySamsung Medical Center Sungkyunkwan University School of MedicineSeoul;

    Department of SurgerySeoul National University College of MedicineSeoul Republic of Korea;

    Department of SurgerySeoul National University College of MedicineSeoul Republic of Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 外科学 ;
  • 关键词

    hepatocellular carcinoma; Milan criteria; survival;

    机译:肝细胞癌;米兰标准;生存;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号